Coming together to take diseases apart.
How do you arrive at revolutionary treatments and breakthroughs? By unleashing a global coalition of brilliant scientific minds, fostering a collaborative process — and doing a world of good.
Every day, we collaborate at the forefront of fundamental and translational science in pursuit of groundbreaking treatment strategies for cancer, Parkinson’s and other diseases. Through shared values and an entrepreneurial spirit, we spark innovation to multiply the impact of discovery and answer critical questions about our world.
Our Research Departments
Scientists in our Department of Cell Biology pursue fundamental research to understand how our cells grow, communicate, survive, assemble into tissues and organs, respond to the environment, and change with age.Learn More
Scientists in our Department of Epigenetics seek to understand how epigenetic changes may either protect us from or predispose us to complex diseases such as cancer, Parkinson’s and metabolic disorders.Learn More
Metabolism and Nutritional Programming
Scientists in our Department of Metabolism and Nutritional Programming explore the intricate mechanics of cellular metabolism and their implications for health and in disease.Learn More
By leveraging discoveries made in VAI’s labs and collaborating with researchers around the world, scientists in our Department of Neurodegenerative Science are working to translate breakthroughs into life-changing new treatments for Parkinson’s, Alzheimer’s and related dementias, and depression.Learn More
Scientists in our Department of Structural Biology harness cryo-electron microscopy and other state-of-the-art techniques to visualize molecules that may serve as treatment targets for cancer, neurological disorders, metabolic diseases, infectious diseases and more.Learn More
Meet Our Scientists
Meet Van Andel Institute’s world-class investigators, learn about their research and check out their latest findings.
2022 Tom Isaacs Award honors leading Parkinson’s researchers and co-authors of Ending Parkinson’s
Craig Reynolds to join Van Andel Institute as Vice President of Research Compliance
Van Andel Institute awarded $7.9 million to continue role as Cancer MoonshotSM Biobank Biorepository
Investing in the postdoctoral trainees of today to enable life-changing discoveries of tomorrow
Inspire Fellow spotlight: A lifelong focus on science, curiosity and diversity
Leveraging curiosity and diversity to elevate research: A Q&A with Dr. Alex Soto-Avellaneda
Van Andel Institute's commitment to collaboration in the U.S. and abroad creates and fuels partnerships to improve human health.
Shared Scientific Resources
Core Technologies and Services
Van Andel Institute’s Core Technologies and Services offer a comprehensive range of advanced technologies and expertise to support and enhance research at the Institute and collaborating organizations.
Business Development and Technology Transfer
Technology and Tools
Business Development and Technology Transfer supports the Institute’s mission by promoting the use of our research results and discoveries for public benefit. We remove barriers to the exchange of information and research materials so that ideas can rapidly be tested in the laboratory and translated to the clinic.
We're raising thousands to save millions
We’re turning hope into action for the millions of people around the world affected by diseases like cancer and Parkinson’s. Find out how you can help us make a difference.
- 88 studies published from Jan. 1, 2022 to Sept. 21, 2022
- 44 studies in high-impact journals from Jan. 1, 2022 to Sept. 21, 2022
- 42 clinical trials launched